RMD ResMed, Inc.

147.101.68 (+1.16%)
Close: November 15, 2019

Quote

Previous Close
$147.10
Day Range
$145.60-$147.38
52 Week Range
$90.64-$149.96
Volume
548,054
Avg Volume
510,185
Dividend TTM
$1.50 (1.03%)
Ex-Dividend Date
2019-11-06

Valuation

Market Cap
$21.15B
Enterprise Value (EV)
$22.03B
PE Ratio
50.36
EV/EBITDA
28.00
Price/Sales
8.02
Price/Book
10.09
PEG Ratio
3.36

Financials

Revenue
$2.61B
Gross Profit
$1.46B
EBITDA
$786.78M
EPS, ttm
$2.92
Profit Margin
15.52%
Revenue/Employee
$360.02K
Next Earnings Date
1/23/2020 (69 days)
Debt to Equity
61%
Debt
$1.03B
Cash
$147.13M
Net Debt
$882.16M

Performance

Beta
0.87
200 Day Moving Avg
$119.43
50 Day Moving Avg
$136.18
52 Week Change
39.52%
YTD Change
31.26%
1 Month Change
11.48%
3 Month Change
9.89%
6 Month Change
28.90%
1 Year Change
39.52%
2 Year Change
72.67%
5 Year Change
177.68%

Share Count

Shares Outstanding
143.8M
Float
142.6M
Restricted Shares
1.2M
Restricted Shares, %
0.81%

ResMed, Inc. Company Details

Sector: Health Technology

Industry: Medical Specialties

CEO: Michael J. Farrell

Website: http://www.resmed.com

Description: ResMed, Inc. engages in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. The company operates through the following segments: Sleep and Respiratory Care, and SaaS. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The SaaS segment engages in the supply of business management software as a service to out-of-hospital health providers. Its product portfolio includes devices, diagnostic products, mask systems, headgear and other accessories, and dental devices. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Employees: 7,240